191 related articles for article (PubMed ID: 21267413)
1. TPL2/COT/MAP3K8 (TPL2) activation promotes androgen depletion-independent (ADI) prostate cancer growth.
Jeong JH; Bhatia A; Toth Z; Oh S; Inn KS; Liao CP; Roy-Burman P; Melamed J; Coetzee GA; Jung JU
PLoS One; 2011 Jan; 6(1):e16205. PubMed ID: 21267413
[TBL] [Abstract][Full Text] [Related]
2. Tpl2 induces castration resistant prostate cancer progression and metastasis.
Lee HW; Cho HJ; Lee SJ; Song HJ; Cho HJ; Park MC; Seol HJ; Lee JI; Kim S; Lee HM; Choi HY; Nam DH; Joo KM
Int J Cancer; 2015 May; 136(9):2065-77. PubMed ID: 25274482
[TBL] [Abstract][Full Text] [Related]
3. Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma.
Lee HW; Joo KM; Lim JE; Cho HJ; Cho HJ; Park MC; Seol HJ; Seo SI; Lee JI; Kim S; Jeong BC; Nam DH
Mol Cancer Res; 2013 Nov; 11(11):1375-86. PubMed ID: 23982215
[TBL] [Abstract][Full Text] [Related]
4. Tumor progression locus 2 (Map3k8) is critical for host defense against Listeria monocytogenes and IL-1 beta production.
Mielke LA; Elkins KL; Wei L; Starr R; Tsichlis PN; O'Shea JJ; Watford WT
J Immunol; 2009 Dec; 183(12):7984-93. PubMed ID: 19933865
[TBL] [Abstract][Full Text] [Related]
5. Deregulated activation of oncoprotein kinase Tpl2/Cot in HTLV-I-transformed T cells.
Babu G; Waterfield M; Chang M; Wu X; Sun SC
J Biol Chem; 2006 May; 281(20):14041-7. PubMed ID: 16565081
[TBL] [Abstract][Full Text] [Related]
6. Cot/Tpl2 regulates IL-23 p19 expression in LPS-stimulated macrophages through ERK activation.
Kakimoto K; Musikacharoen T; Chiba N; Bandow K; Ohnishi T; Matsuguchi T
J Physiol Biochem; 2010 Mar; 66(1):47-53. PubMed ID: 20405269
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.
Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS
Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217
[TBL] [Abstract][Full Text] [Related]
8. Tpl2 kinase is upregulated in adipose tissue in obesity and may mediate interleukin-1beta and tumor necrosis factor-{alpha} effects on extracellular signal-regulated kinase activation and lipolysis.
Jager J; Grémeaux T; Gonzalez T; Bonnafous S; Debard C; Laville M; Vidal H; Tran A; Gual P; Le Marchand-Brustel Y; Cormont M; Tanti JF
Diabetes; 2010 Jan; 59(1):61-70. PubMed ID: 19808894
[TBL] [Abstract][Full Text] [Related]
9. Tpl2/AP-1 enhances murine gammaherpesvirus 68 lytic replication.
Li X; Feng J; Chen S; Peng L; He WW; Qi J; Deng H; Sun R
J Virol; 2010 Feb; 84(4):1881-90. PubMed ID: 19939924
[TBL] [Abstract][Full Text] [Related]
10. A serine/threonine kinase, Cot/Tpl2, modulates bacterial DNA-induced IL-12 production and Th cell differentiation.
Sugimoto K; Ohata M; Miyoshi J; Ishizaki H; Tsuboi N; Masuda A; Yoshikai Y; Takamoto M; Sugane K; Matsuo S; Shimada Y; Matsuguchi T
J Clin Invest; 2004 Sep; 114(6):857-66. PubMed ID: 15372110
[TBL] [Abstract][Full Text] [Related]
11. TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations.
Dodhiawala PB; Khurana N; Zhang D; Cheng Y; Li L; Wei Q; Seehra K; Jiang H; Grierson PM; Wang-Gillam A; Lim KH
J Clin Invest; 2020 Sep; 130(9):4771-4790. PubMed ID: 32573499
[TBL] [Abstract][Full Text] [Related]
12. Serine/threonine kinase, Cot/Tpl2, regulates renal cell apoptosis in ischaemia/reperfusion injury.
Yaomura T; Tsuboi N; Urahama Y; Hobo A; Sugimoto K; Miyoshi J; Matsuguchi T; Reiji K; Matsuo S; Yuzawa Y
Nephrology (Carlton); 2008 Oct; 13(5):397-404. PubMed ID: 18518937
[TBL] [Abstract][Full Text] [Related]
13. The kinase TPL2 activates ERK and p38 signaling to promote neutrophilic inflammation.
Senger K; Pham VC; Varfolomeev E; Hackney JA; Corzo CA; Collier J; Lau VWC; Huang Z; Hamidzhadeh K; Caplazi P; Peng I; Setiadi AF; Francis R; Paler-Martinez A; Kwon YC; Ramirez-Carrozzi V; Sun Y; Grigg PW; Roose-Girma M; Jeet S; Barck KH; Pham A; Ota N; Ha C; Stinson J; Guillory J; Tam L; Modrusan Z; Emson C; McKenzie BS; Townsend MJ; Carano RAD; Warming S; Vucic D; DeVoss J; Lee WP; Lill JR; Zarrin AA
Sci Signal; 2017 Apr; 10(475):. PubMed ID: 28420753
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of threonine 290 in the activation loop of Tpl2/Cot is necessary but not sufficient for kinase activity.
Luciano BS; Hsu S; Channavajhala PL; Lin LL; Cuozzo JW
J Biol Chem; 2004 Dec; 279(50):52117-23. PubMed ID: 15466476
[TBL] [Abstract][Full Text] [Related]
15. Cot/tpl2 participates in the activation of macrophages by adiponectin.
Sanz-Garcia C; Nagy LE; Lasunción MA; Fernandez M; Alemany S
J Leukoc Biol; 2014 Jun; 95(6):917-30. PubMed ID: 24532642
[TBL] [Abstract][Full Text] [Related]
16. Tpl2 (tumor progression locus 2) phosphorylation at Thr290 is induced by lipopolysaccharide via an Ikappa-B Kinase-beta-dependent pathway and is required for Tpl2 activation by external signals.
Cho J; Melnick M; Solidakis GP; Tsichlis PN
J Biol Chem; 2005 May; 280(21):20442-8. PubMed ID: 15778223
[TBL] [Abstract][Full Text] [Related]
17. TPL2 kinase regulates the inflammatory milieu of the myeloma niche.
Hope C; Ollar SJ; Heninger E; Hebron E; Jensen JL; Kim J; Maroulakou I; Miyamoto S; Leith C; Yang DT; Callander N; Hematti P; Chesi M; Bergsagel PL; Asimakopoulos F
Blood; 2014 May; 123(21):3305-15. PubMed ID: 24723682
[TBL] [Abstract][Full Text] [Related]
18. Cot/tpl2 (MAP3K8) mediates myeloperoxidase activity and hypernociception following peripheral inflammation.
Soria-Castro I; Krzyzanowska A; Pelaéz ML; Regadera J; Ferrer G; Montoliu L; Rodríguez-Ramos R; Fernández M; Alemany S
J Biol Chem; 2010 Oct; 285(44):33805-15. PubMed ID: 20736176
[TBL] [Abstract][Full Text] [Related]
19. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
[TBL] [Abstract][Full Text] [Related]
20. Cot/tpl2 activity is required for TLR-induced activation of the Akt p70 S6k pathway in macrophages: Implications for NO synthase 2 expression.
López-Peláez M; Soria-Castro I; Boscá L; Fernández M; Alemany S
Eur J Immunol; 2011 Jun; 41(6):1733-41. PubMed ID: 21469113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
